Schistosomiasis :: Merck KGaA & WHO conclude partnership to control Schistosomiasis in Africa
Merck KGaA announced the conclusion of a ten-year partnership with WHO to control schistosomiasis in African schoolchildren. For this purpose, Merck will provide for free 200 million tablets Cesol? 600 (active ingredient praziquantel) with a value of approximately US$ 80 million.